Stay Updated
Press Releases
New Video Makes Case For Affordable COVID-19 Drugs
WASHINGTON, DC –– In a video released today, Patients For Affordable Drugs juxtaposes the history of polio vaccine development in the 1950s with the current race to develop a COVID-19 vaccine. While polio vaccine inventor Jonas Salk refused to profit off of his life-saving creation, modern day pharmaceutical companies stand to reap huge profits on […]
Press Releases
WASHINGTON, DC — While COVID-19 has claimed more than 110,000 American lives, it’s business as usual for Wall Street and Big Pharma. In a new blog post, Patients For Affordable Drugs examines how drug corporations and Wall Street together push for high prices on COVID-19 treatments and vaccines developed with taxpayer support. The piece looks […]
Press Releases
U.S. Taxpayers Are Mega-Funders in Promising COVID-19 Vaccine
WASHINGTON, DC — The growing crisis around COVID-19 brings into stark view America’s broken drug pricing system. Currently, U.S. taxpayers are contributing up to $483 million in support of a COVID-19 vaccine from Moderna Therapeutics. In a blog published today, Patients For Affordable Drugs argues that as partners funding the science, development, and approval of […]
Press Releases
PRESS RELEASE: A “Not-For-Profit” Vaccine From Johnson & Johnson?
Washington, D.C. — Johnson & Johnson is facing new questions from Patients For Affordable Drugs after our analysis found the drug company’s promise to offer a not-for-profit COVID-19 vaccine is more than a little misleading. As Johnson & Johnson (J&J) garnered positive press for its announcement, a closer look found that based on the company’s […]
Press Releases
Drug Corporations Didn't Invest in Vaccines Until a Global Pandemic
WASHINGTON, DC — In a new review, Patients For Affordable Drugs examined the drug industry’s historic disinterest in vaccines and treatments for global pandemics like COVID-19. P4AD found that while public health experts have warned of a pandemic for years, drug corporations were uninterested in developing new drugs until it was clear that vaccines and […]
Press Releases
Statement: Public-Private Partnership to Drive COVID-19 Research Overlooks Drug Prices
WASHINGTON, DC — In response to the new NIH-led public-private partnership to accelerate COVID-19 treatments and vaccines, David Mitchell, a cancer patient and the founder of Patients For Affordable Drugs, issued the following statement: “We are glad the federal government is directing billions of taxpayer dollars to find treatments and vaccines for COVID-19. But since […]
Press Releases
Tracking COVID-19 Funds: How U.S. Taxpayers Are Investing in Vaccines and Treatments
WASHINGTON, D.C. — A new analysis by Patients For Affordable Drugs found that in one week in March, U.S. taxpayers gave more than $700 million to just three drug companies for research and development into COVID-19 vaccines and treatment. Today’s review — the first in a three-part series that will examine taxpayer investment into COVID-19 […]
Press Releases
Patients Call On Insulin Manufacturers To Respond To Covid-19 Pandemic And Lower List Prices
WASHINGTON, D.C. — With research showing that patients with diabetes have a higher mortality rate and are more likely to experience complications from COVID-19, Patients For Affordable Drugs and 63 people living with diabetes penned a letter to the Big 3 insulin manufacturers urging them to take action to lower the list prices of their […]